Mitra Bio is a groundbreaking brand that is revolutionizing skincare with the power of genomics. Established in 2020, their mission is to enhance healthspan and enable personalized therapies for the skin using genomic data. Mitra has developed an innovative non-invasive skin diagnostics platform that fuels the creation of age-rejuvenating compounds.

Through a combination of cutting-edge techniques such as clinical trials, non-invasive skin sampling, next-generation sequencing, and advanced data science, Mitra guides the formulation of novel skincare compounds that directly target the human skin. At the helm of Mitra Bio is a visionary executive team. Co-founder and CEO Shakiba Kaveh is a strategic leader with a deep passion for introducing genomics-led innovations to the skincare market.

She brings her extensive experience from the skincare industry and is an alumna of Cambridge University. Co-founder and CSO Cristiana Banila, a molecular biologist, has made significant contributions to the development of an epigenetic test for cervical cancer screening. She is now driving the development of epigenetic skin tests for Mitra Bio, drawing from her impressive educational background with degrees from Oxford and Princeton.

Mitra Bio is supported by esteemed advisors, including Dr. Magnus Lynch, a dermatologist, Jim Mainard, a business advisor, and Stephan Scruton, a finance advisor. Join the waitlist for Mitra Bio's groundbreaking skincare solutions and become a part of their mission to redefine skincare through genomics